Skip to content

Faith Moves Mountains: A Community Based Participatory Research (CBPR) Appalachian Wellness & Cancer Prevention Program

Faith Moves Mountains: A CBPR Appalachian Wellness & Cancer Prevention Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01373320
Enrollment
1415
Registered
2011-06-14
Start date
2010-03-31
Completion date
2012-11-30
Last updated
2013-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer

Keywords

Smoking cessation, Cancer screening, Appalachia, Group-randomized trial, Faith-placed

Brief summary

The study purpose is to evaluate the effectiveness of a set of culturally appropriate, faith-placed lay health advisor interventions aimed at facilitating smoking cessation and increasing cancer screening among Appalachian participants.

Detailed description

The developmental phase of this project incorporated community based participatory research (CBPR) principles to identify the needs and preferences of community members with regard to cancer prevention. In the intervention phase, this group-randomized trial administers and evaluates a set of culturally appropriate interventions aimed at facilitating smoking cessation and increasing cancer screening among participants in 6 distressed Appalachian counties. Faith institutions are recruited and randomized to treatment or wait-list control conditions, and participants are recruited and enrolled within those institutions. Participants select one or more targeted health behaviors from a menu including smoking cessation, colorectal cancer screening, cervical cancer screening, and breast cancer screening, and subsequently receive the intervention(s) aimed at their selected health behaviors.

Interventions

BEHAVIORALLay health advisor interactions

For smoking cessation: Cooper-Clayton group sessions plus motivational interviewing, both delivered by local lay health advisor. For all cancer screenings: lay health advisor home visits incorporating motivational interviewing and focused on decreasing participant-identified barriers to screening.

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
Nancy Schoenberg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* For smoking cessation: age 18 or older; current cigarette smoker; able to provide informed consent * For cervical cancer screening: female; age 18 or older AND outside of screening guidelines; able to provide informed consent * For breast cancer screening: female; age 40 or older AND outside of screening guidelines; able to provide informed consent * For colorectal cancer screening: age 40 or older AND outside of screening guidelines; able to provide informed consent

Exclusion criteria

* For smoking cessation: None * For cervical cancer screening: History of cervical cancer; history of hysterectomy * For breast cancer screening: History of breast cancer * For colorectal cancer screening: History of colorectal cancer

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants reporting the health behavior of interest (depending on which intervention component(s) were selected)Assessed approximately 4 months after baselineFor smoking cessation: Self-reported smoking status. For cancer screenings: Self-reported receipt of cervical, breast, and/or colorectal cancer screening. This assessment occurs after the Early Treatment group has completed the intervention.

Secondary

MeasureTime frameDescription
Change in stage of readiness to change the selected health behavior(s) from baselineAssessed approximately 4 months after baselineMeasured using reliable and valid instruments which were pretested in focus groups comprised of members of the target population. Positive change (i.e., increasing stage of readiness) from baseline to post-test will be coded as 1, while negative or no change will be coded 0. This assessment occurs after the Early Treatment group has completed the intervention.
Number of visits completedApproximately 4 months after baselineThis process measure will reflect the number of visits/classes attended by participants, as a means of assessing participation rate and feasibility.
Retention (i.e., number of participants who complete all planned assessment timepoints)Approximately one year after baselineRetention numbers will be assessed as a process measure outcome. Participants who complete all study assessment timepoints will be coded as 1, while participants who drop out will be coded 0. Number/percentage of participants who remained enrolled and complete all study procedures and assessments will be used as an indicator of feasibility in the community setting.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026